These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23159458)

  • 1. Waning immunity to measles in young adults and booster effects of revaccination in secondary school students.
    He H; Chen EF; Li Q; Wang Z; Yan R; Fu J; Pan J
    Vaccine; 2013 Jan; 31(3):533-7. PubMed ID: 23159458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles outbreak in Juneau, Alaska, 1996: implications for future outbreak control strategies.
    Landen MG; Beller M; Funk E; Rolka HR; Middaugh J
    Pediatrics; 1998 Dec; 102(6):E71. PubMed ID: 9832599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroresponse to the second measles vaccine dose at school entry in Qassim province, Saudi Arabia.
    Khalil MK; Nadrah HM; Al Yahia OA; ElGhazali G
    East Mediterr Health J; 2011 Mar; 17(3):191-5. PubMed ID: 21735958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on factors associated with seroprotection after measles vaccination in children of 6-14 years in Eastern China.
    Yan R; He H; Zhou Y; Xie S; Deng X; Tang X
    Vaccine; 2019 Aug; 37(36):5185-5190. PubMed ID: 31377078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles revaccination response in a school-age population.
    Wittler RR; Veit BC; McIntyre S; Schydlower M
    Pediatrics; 1991 Nov; 88(5):1024-30. PubMed ID: 1945606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to measles revaccination among Bolivian school-aged children.
    Bartoloni A; Cutts FT; Guglielmetti P; Brown D; Bianchi Bandinelli ML; Hurtado H; Roselli M
    Trans R Soc Trop Med Hyg; 1997; 91(6):716-8. PubMed ID: 9509188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning population immunity to measles in Taiwan.
    Chen CJ; Lee PI; Hsieh YC; Chen PY; Ho YH; Chang CJ; Liu DP; Chang FY; Chiu CH; Huang YC; Lee CY; Lin TY
    Vaccine; 2012 Oct; 30(47):6721-7. PubMed ID: 22634294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identify the susceptibility profile to measles in the general population: Serological survey of measles antibodies in Shaanxi province, China, in 2016.
    Pei L; Yang Y; Zhao X; Zhang S; Yuan L; Liu Y; Yu Y
    Vaccine; 2017 Dec; 35(52):7250-7255. PubMed ID: 29153585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of measles among children affected by national measles elimination program in Korea, 2010.
    Kim ES; Choe YJ; Cho H; Kim YJ; Yoon HS; Yang JS; Kim K; Bae GR; Lee DH
    Vaccine; 2012 May; 30(23):3355-9. PubMed ID: 22484294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A measles outbreak in a middle school with high vaccination coverage and evidence of prior immunity among cases, Beijing, P.R. China.
    Ma R; Lu L; Zhangzhu J; Chen M; Yu X; Wang F; Peng X; Wu J
    Vaccine; 2016 Apr; 34(15):1853-60. PubMed ID: 26589518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015.
    Tang L; Zhou Y; Pan Y; Zhu H
    Vaccine; 2017 May; 35(22):2925-2929. PubMed ID: 28433329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measles: immunity and vaccination status in Greater Frankfurt on the Main].
    Friedrichs I; Doerr HW; Allwinn R
    Dtsch Med Wochenschr; 2012 Jan; 137(4):121-5. PubMed ID: 22259164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.